Natera, Inc. SEC filings NTRA

Natera, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 11, 2022. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Natera, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 11, 2026
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 12, 2025
DEFA14A Additional proxy material Jun 5, 2024 —
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Jun 12, 2024
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 —

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
NTRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
Large accelerated filer
SEC CIK
1604821
Former names
Natera, Inc. (until Nov 5, 2026)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.